Gland Pharma Limited
NSE: GLAND · Healthcare
₹2,824.60
+23.00 (+0.82%)
Last close · 30 Aug 2026, 6:42 am IST
- Open
- ₹2,810.90
- Day high
- ₹2,835.90
- Day low
- ₹2,776.10
- Volume
- 1.39 L
- Prev close
- ₹2,801.60
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty Midcap 150Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 39,257 Cr
- Price
- 2,379.80
- P/E (TTM)
- 38.17
- P/E (Fwd)
- 26.16
- P/B
- 3.78
- EV/EBITDA
- 22.12
- EV/Revenue
- 5.61
- PEG
- —
- Div Yield
- 0.84%
- 52W High
- 2,573.50
- 52W Low
- 1,573.60
- Beta
- 0.49
Profitability & income
- Revenue (TTM)
- 6,431 Cr
- Net Income (TTM)
- 1,027 Cr
- EBITDA
- 1,630 Cr
- Gross Margin
- 61.97%
- Op. Margin
- 23.20%
- Net Margin
- 15.98%
- ROE
- 10.53%
- ROA
- 6.35%
- EPS (TTM)
- 62.35
- EPS (Fwd)
- 90.97
Financial health
- Total Debt
- 284 Cr
- Total Cash
- 3,433 Cr
- Debt/Equity
- 2.74
- Current Ratio
- 4.68
- Quick Ratio
- 3.31
- Book Value
- 628.81
- Free Cash Flow
- 504 Cr
- Op. Cash Flow
- 1,031 Cr
Growth
- Revenue Growth
- 22.30%
- Earnings Growth
- 96.40%
- Earnings QoQ
- 96.60%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,743 Cr | 367 Cr | 624 Cr | 404 Cr | 1,151 Cr | — | 284 Cr | 10,358 Cr |
| 2025-12-31 | 1,695 Cr | 261 Cr | 474 Cr | 327 Cr | 1,119 Cr | — | — | — |
| 2025-06-30 | 1,506 Cr | 215 Cr | 425 Cr | 267 Cr | 984 Cr | — | — | — |
| 2025-03-31 | 1,425 Cr | 187 Cr | 392 Cr | 252 Cr | 937 Cr | — | 314 Cr | 9,151 Cr |
| 2024-12-31 | 1,384 Cr | 205 Cr | 418 Cr | 264 Cr | 921 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 6,431 Cr | 1,027 Cr | 1,922 Cr | 1,206 Cr | 4,188 Cr | 1,031 Cr | 284 Cr | 10,358 Cr |
| 2025-03-31 | 5,617 Cr | 699 Cr | 1,483 Cr | 891 Cr | 3,526 Cr | 915 Cr | 314 Cr | 9,151 Cr |
| 2024-03-31 | 5,642 Cr | 772 Cr | 1,499 Cr | 996 Cr | 3,469 Cr | 997 Cr | 372 Cr | 8,724 Cr |
| 2023-03-31 | 3,592 Cr | 781 Cr | 1,208 Cr | 870 Cr | 1,906 Cr | 364 Cr | 4 Cr | 7,959 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for GLAND?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in